5,800
Participants
Start Date
June 26, 2025
Primary Completion Date
June 30, 2028
Study Completion Date
March 30, 2029
Meropenem
For meropenem, the standard dose is 1 g administered 3 times daily as a 30-minute intravenous (IV) infusion, and the high dose is 2 g administered 3 times daily by extended 3-hour infusion
Piperacillin/Tazobactam
Standard dose of piperacillin/tazobactam 4/0.5 g administered 4 times daily as a 30-minute intravenous (IV) infusion or 3 times daily by extended 4-hour infusions and the recommended high dose is 4/0.5 g administered 4 times daily by extended 3-hour infusion
NOT_YET_RECRUITING
Rigshospitalet, Copenhagen
RECRUITING
Rigshospitalet, Copenhagen
Scandinavian Critical Care Trials Group
OTHER